Cell Host Microbe
. 2021 Jun 4;S1931-3128(21)00279-1.
doi: 10.1016/j.chom.2021.06.001. Online ahead of print.
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin 1 , Manon Nayrac 1 , Mehdi Benlarbi 2 , Shang Yu Gong 3 , Romain Gasser 1 , Guillaume Beaudoin-Bussières 1 , Nathalie Brassard 2 , Annemarie Laumaea 1 , Dani Vézina 1 , Jérémie Prévost 1 , Sai Priya Anand 3 , Catherine Bourassa 2 , Gabrielle Gendron-Lepage 2 , Halima Medjahed 2 , Guillaume Goyette 2 , Julia Niessl 4 , Olivier Tastet 2 , Laurie Gokool 2 , Chantal Morrisseau 2 , Pascale Arlotto 2 , Leonidas Stamatatos 5 , Andrew T McGuire 6 , Catherine Larochelle 7 , Pradeep Uchil 8 , Maolin Lu 8 , Walther Mothes 8 , Gaston De Serres 9 , Sandrine Moreira 10 , Michel Roger 11 , Jonathan Richard 1 , Valérie Martel-Laferrière 1 , Ralf Duerr 12 , Cécile Tremblay 13 , Daniel E Kaufmann 14 , Andrés Finzi 15
Affiliations
- PMID: 34133950
- DOI: 10.1016/j.chom.2021.06.001
Abstract
While the standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two doses administered 3 weeks apart, some public health authorities are spacing these doses, raising concerns about efficacy. However, data indicate that a single dose can be up to 90% effective starting 14 days post-administration. To assess the mechanisms contributing to protection, we analyzed humoral and T cell responses three weeks after a single BNT162b2 dose. We observed weak neutralizing activity elicited in SARS-CoV-2 naive individuals but strong anti-receptor binding domain and spike antibodies with Fc-mediated effector functions and cellular CD4+ T cell responses. In previously infected individuals, a single dose boosted all humoral and T cell responses, with strong correlations between T helper and antibody immunity. Our results highlight the potential role of Fc-mediated effector functions and T cell responses in vaccine efficacy. They also provide support for spacing doses to vaccinate more individuals in conditions of vaccine scarcity.
Keywords: ADCC; COVID-19; SARS-CoV-2; T cell responses; coronavirus; humoral responses; mRNA vaccine; neutralization; spike glycoproteins; variants.